Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Obagi Medical Products, Inc. (OMPI) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Obagi Medical Products, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1375247.
Total stock buying since 2010: $0.
Total stock sales since 2010: $29,481,194.
Total stock option exercises since 2010: $1,897,413.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2012 | 0 | $0 | 112,137 | $1,466,759 | 112,137 | $1,015,848 |
| 2011 | 0 | $0 | 89,168 | $871,450 | 66,668 | $390,672 |
| 2010 | 0 | $0 | 2,739,086 | $27,142,985 | 50,418 | $490,893 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2012-09 | 0 | $0 | 95,471 | $1,258,285 | 95,471 | $918,186 |
| 2012-03 | 0 | $0 | 16,666 | $208,474 | 16,666 | $97,662 |
| 2011-12 | 0 | $0 | 55,834 | $544,472 | 33,334 | $195,337 |
| 2011-11 | 0 | $0 | 33,334 | $326,978 | 33,334 | $195,335 |
| 2010-11 | 0 | $0 | 2,688,668 | $26,456,493 | 0 | $0 |
| 2010-05 | 0 | $0 | 50,418 | $686,492 | 50,418 | $490,893 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-09-11 | Romm Preston S (CFO and EVP) | Sale | 77,827 | 13.16 | 1,024,203 |
| 2012-09-11 | Romm Preston S (CFO and EVP) | Option Ex | 77,827 | 10.00 | 778,270 |
| 2012-09-10 | Romm Preston S (CFO and EVP) | Sale | 17,644 | 13.27 | 234,082 |
| 2012-09-10 | Romm Preston S (CFO and EVP) | Option Ex | 17,644 | 7.93 | 139,916 |
| 2012-03-13 | Goldstein David S. (Executive Vice President) | Sale | 16,666 | 12.51 | 208,474 |
| 2012-03-13 | Goldstein David S. (Executive Vice President) | Option Ex | 16,666 | 5.86 | 97,662 |
| 2011-12-09 | Goldstein David S. (Executive Vice President) | Sale | 54,834 | 9.75 | 534,631 |
| 2011-12-09 | Goldstein David S. (Executive Vice President) | Option Ex | 33,334 | 5.86 | 195,337 |
| 2011-12-08 | Goldstein David S. (Executive Vice President) | Sale | 1,000 | 9.84 | 9,841 |
| 2011-11-18 | Romm Preston S (CFO and EVP) | Sale | 13,179 | 9.72 | 128,060 |
| 2011-11-18 | Romm Preston S (CFO and EVP) | Option Ex | 13,179 | 5.86 | 77,228 |
| 2011-11-17 | Romm Preston S (CFO and EVP) | Sale | 10,569 | 9.80 | 103,586 |
| 2011-11-17 | Romm Preston S (CFO and EVP) | Option Ex | 10,569 | 5.86 | 61,934 |
| 2011-11-16 | Romm Preston S (CFO and EVP) | Sale | 9,586 | 9.95 | 95,332 |
| 2011-11-16 | Romm Preston S (CFO and EVP) | Option Ex | 9,586 | 5.86 | 56,173 |
| 2010-11-30 | Stonington Partners Inc Ii | Sale | 2,688,668 | 9.84 | 26,456,493 |
| 2010-05-13 | Goldstein David S. (Executive Vice President) | Sale | 8,601 | 13.55 | 116,569 |
| 2010-05-13 | Goldstein David S. (Executive Vice President) | Option Ex | 8,601 | 10.40 | 89,450 |
| 2010-05-12 | Goldstein David S. (Executive Vice President) | Sale | 41,817 | 13.63 | 569,923 |
| 2010-05-12 | Goldstein David S. (Executive Vice President) | Option Ex | 41,817 | 9.60 | 401,443 |
Insider trading activities including stock purchases, stock sales, and option exercises of OMPI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Obagi Medical Products, Inc. (symbol OMPI, CIK number 1375247) see the Securities and Exchange Commission (SEC) website.